Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chondrocytes | 13 | 2020 | 203 | 1.990 |
Why?
|
| SOX9 Transcription Factor | 7 | 2016 | 14 | 1.770 |
Why?
|
| Nucleus Pulposus | 2 | 2016 | 12 | 1.080 |
Why?
|
| Protein Kinase C | 13 | 2003 | 47 | 0.820 |
Why?
|
| Mitogen-Activated Protein Kinases | 13 | 2003 | 28 | 0.820 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 282 | 0.690 |
Why?
|
| Annulus Fibrosus | 2 | 2017 | 9 | 0.680 |
Why?
|
| Cell Differentiation | 8 | 2016 | 153 | 0.590 |
Why?
|
| Animals | 26 | 2023 | 4654 | 0.590 |
Why?
|
| Cells, Cultured | 15 | 2020 | 686 | 0.590 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 1 | 0.550 |
Why?
|
| Growth Plate | 1 | 2016 | 23 | 0.540 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2014 | 132 | 0.540 |
Why?
|
| Pyridines | 2 | 2016 | 45 | 0.540 |
Why?
|
| rho-Associated Kinases | 1 | 2016 | 6 | 0.540 |
Why?
|
| Collagen Type II | 4 | 2016 | 33 | 0.530 |
Why?
|
| Amides | 1 | 2016 | 21 | 0.530 |
Why?
|
| Signal Transduction | 13 | 2020 | 493 | 0.530 |
Why?
|
| Chondrogenesis | 5 | 2003 | 30 | 0.490 |
Why?
|
| Isoenzymes | 8 | 2002 | 54 | 0.440 |
Why?
|
| Mesoderm | 8 | 2003 | 19 | 0.440 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 2000 | 19 | 0.390 |
Why?
|
| Cartilage, Articular | 5 | 2020 | 534 | 0.380 |
Why?
|
| Apoptosis | 5 | 2003 | 259 | 0.370 |
Why?
|
| Genome | 1 | 2010 | 14 | 0.360 |
Why?
|
| Binding Sites | 3 | 2016 | 75 | 0.350 |
Why?
|
| Mice, Knockout | 5 | 2020 | 315 | 0.340 |
Why?
|
| Rats | 4 | 2016 | 875 | 0.330 |
Why?
|
| Mice | 10 | 2023 | 1647 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 7 | 2003 | 17 | 0.290 |
Why?
|
| Intervertebral Disc Degeneration | 2 | 2022 | 117 | 0.290 |
Why?
|
| Cartilage | 6 | 2010 | 154 | 0.270 |
Why?
|
| Enzyme Inhibitors | 8 | 2016 | 147 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 11 | 2003 | 22 | 0.240 |
Why?
|
| Osteoarthritis | 2 | 2020 | 366 | 0.230 |
Why?
|
| Nitric Oxide | 5 | 2003 | 103 | 0.230 |
Why?
|
| Intervertebral Disc | 2 | 2016 | 217 | 0.220 |
Why?
|
| Endothelial Cells | 1 | 2023 | 65 | 0.220 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 41 | 0.220 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 58 | 0.210 |
Why?
|
| Bone Regeneration | 1 | 2023 | 75 | 0.210 |
Why?
|
| Enzyme Activation | 9 | 2003 | 112 | 0.210 |
Why?
|
| Chick Embryo | 8 | 2003 | 20 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 8 | 2003 | 34 | 0.210 |
Why?
|
| Microbiota | 1 | 2023 | 105 | 0.210 |
Why?
|
| Caspases | 5 | 2003 | 33 | 0.200 |
Why?
|
| Awards and Prizes | 1 | 2022 | 25 | 0.200 |
Why?
|
| Macrophages | 2 | 1999 | 130 | 0.200 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 161 | 0.200 |
Why?
|
| Sirolimus | 1 | 2001 | 18 | 0.200 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 180 | 0.190 |
Why?
|
| Malocclusion | 1 | 2020 | 1 | 0.190 |
Why?
|
| Osteogenesis | 2 | 2023 | 103 | 0.180 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2020 | 6 | 0.180 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2022 | 121 | 0.180 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 134 | 0.180 |
Why?
|
| Low Back Pain | 1 | 2022 | 139 | 0.180 |
Why?
|
| Receptors, Vitronectin | 1 | 2000 | 5 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 15 | 0.170 |
Why?
|
| Receptors, Laminin | 1 | 1999 | 1 | 0.170 |
Why?
|
| Metformin | 1 | 2020 | 23 | 0.170 |
Why?
|
| Up-Regulation | 1 | 2020 | 173 | 0.170 |
Why?
|
| Menisci, Tibial | 2 | 2020 | 172 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2016 | 12 | 0.160 |
Why?
|
| Cell Proliferation | 2 | 2016 | 208 | 0.160 |
Why?
|
| Base Sequence | 2 | 2016 | 131 | 0.150 |
Why?
|
| Gene Expression | 2 | 2017 | 235 | 0.150 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2017 | 36 | 0.140 |
Why?
|
| Receptors, CCR5 | 1 | 2017 | 29 | 0.140 |
Why?
|
| Introns | 1 | 2016 | 16 | 0.140 |
Why?
|
| Sternum | 1 | 2016 | 5 | 0.140 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2016 | 9 | 0.140 |
Why?
|
| Gene Deletion | 1 | 2016 | 42 | 0.140 |
Why?
|
| Extremities | 1 | 2016 | 33 | 0.140 |
Why?
|
| Cell Movement | 1 | 2017 | 108 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 82 | 0.140 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 17 | 0.130 |
Why?
|
| Osteoblasts | 1 | 2016 | 63 | 0.130 |
Why?
|
| Interleukin-1 | 2 | 2014 | 79 | 0.130 |
Why?
|
| Protein Binding | 2 | 2014 | 124 | 0.130 |
Why?
|
| Bone and Bones | 2 | 2023 | 124 | 0.130 |
Why?
|
| RNA, Messenger | 1 | 2016 | 325 | 0.130 |
Why?
|
| Cadherins | 4 | 2003 | 31 | 0.120 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2014 | 1 | 0.120 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 2 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 19 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 463 | 0.120 |
Why?
|
| Protein Transport | 1 | 2014 | 39 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 38 | 0.120 |
Why?
|
| Trans-Activators | 3 | 2003 | 28 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2014 | 44 | 0.120 |
Why?
|
| Cell Line | 3 | 2010 | 300 | 0.120 |
Why?
|
| Humans | 10 | 2023 | 29830 | 0.110 |
Why?
|
| Blotting, Western | 3 | 2003 | 176 | 0.110 |
Why?
|
| Down-Regulation | 4 | 2016 | 113 | 0.110 |
Why?
|
| Cell Division | 3 | 2001 | 112 | 0.100 |
Why?
|
| Inflammation | 1 | 2014 | 348 | 0.100 |
Why?
|
| Caspase 3 | 5 | 2003 | 30 | 0.100 |
Why?
|
| Protein Kinase C-alpha | 5 | 2002 | 6 | 0.100 |
Why?
|
| Fibronectins | 3 | 2000 | 31 | 0.100 |
Why?
|
| Cell Adhesion | 3 | 2000 | 45 | 0.100 |
Why?
|
| Limb Buds | 2 | 2009 | 2 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 455 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 5 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 25 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 58 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2000 | 30 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 34 | 0.090 |
Why?
|
| Rabbits | 4 | 2003 | 283 | 0.090 |
Why?
|
| Integrins | 2 | 2000 | 20 | 0.090 |
Why?
|
| Body Patterning | 1 | 2009 | 3 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 70 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 3 | 2003 | 25 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 748 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2001 | 159 | 0.070 |
Why?
|
| Collagen | 3 | 2003 | 102 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 414 | 0.070 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2017 | 31 | 0.070 |
Why?
|
| Disease Progression | 2 | 2020 | 812 | 0.060 |
Why?
|
| Flavonoids | 5 | 2003 | 19 | 0.060 |
Why?
|
| Tretinoin | 1 | 2003 | 15 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2003 | 16 | 0.060 |
Why?
|
| Bacteria | 1 | 2023 | 76 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 55 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 47 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2023 | 78 | 0.050 |
Why?
|
| Oxygen | 1 | 2023 | 86 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 260 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1999 | 37 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2003 | 111 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 2 | 2000 | 40 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 1 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 45 | 0.050 |
Why?
|
| Carbazoles | 1 | 2000 | 6 | 0.050 |
Why?
|
| Facial Pain | 1 | 2020 | 5 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 91 | 0.050 |
Why?
|
| Nociception | 1 | 2020 | 9 | 0.050 |
Why?
|
| Temporomandibular Joint | 1 | 2020 | 14 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2000 | 59 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2020 | 6 | 0.040 |
Why?
|
| Cell Fractionation | 1 | 2000 | 6 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 32 | 0.040 |
Why?
|
| Integrin alpha6beta1 | 1 | 1999 | 1 | 0.040 |
Why?
|
| Protein Kinase C-delta | 1 | 1999 | 11 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 143 | 0.040 |
Why?
|
| Laminin | 1 | 1999 | 8 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 57 | 0.040 |
Why?
|
| Receptors, Muscarinic | 1 | 1999 | 6 | 0.040 |
Why?
|
| Time Factors | 2 | 2001 | 1640 | 0.040 |
Why?
|
| Proteoglycans | 2 | 2014 | 346 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 558 | 0.040 |
Why?
|
| beta Catenin | 3 | 2003 | 49 | 0.040 |
Why?
|
| Child | 1 | 2022 | 1376 | 0.040 |
Why?
|
| Nitroprusside | 3 | 2002 | 6 | 0.040 |
Why?
|
| SOXD Transcription Factors | 1 | 2016 | 1 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 79 | 0.040 |
Why?
|
| Aggrecans | 1 | 2017 | 155 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 108 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 1247 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 33 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2022 | 490 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 273 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 2466 | 0.030 |
Why?
|
| ADAMTS5 Protein | 1 | 2014 | 28 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 351 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 128 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 75 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 215 | 0.030 |
Why?
|
| Cattle | 1 | 2014 | 218 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2014 | 65 | 0.030 |
Why?
|
| Homeostasis | 1 | 2014 | 85 | 0.030 |
Why?
|
| alpha Catenin | 2 | 2003 | 2 | 0.030 |
Why?
|
| Nitric Oxide Donors | 2 | 2002 | 7 | 0.030 |
Why?
|
| Phenotype | 2 | 2002 | 363 | 0.020 |
Why?
|
| Caspase Inhibitors | 2 | 2001 | 5 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 16 | 0.020 |
Why?
|
| Chromatin | 1 | 2010 | 14 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 63 | 0.020 |
Why?
|
| DNA | 1 | 2010 | 122 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 254 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 1999 | 13 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 396 | 0.020 |
Why?
|
| Male | 1 | 2022 | 15858 | 0.020 |
Why?
|
| Female | 1 | 2022 | 16417 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2003 | 6 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2002 | 10 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 29 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2002 | 10 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 53 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 191 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 27 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 29 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 203 | 0.010 |
Why?
|
| Imidazoles | 1 | 2001 | 72 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2000 | 1 | 0.010 |
Why?
|
| Receptors, Fibronectin | 1 | 2000 | 1 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2000 | 14 | 0.010 |
Why?
|
| Pyrroles | 1 | 2000 | 23 | 0.010 |
Why?
|
| Indoles | 1 | 2000 | 51 | 0.010 |
Why?
|
| Models, Biological | 1 | 2001 | 348 | 0.010 |
Why?
|
| Bucladesine | 1 | 1999 | 2 | 0.010 |
Why?
|
| Mitogens | 1 | 1999 | 7 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1999 | 14 | 0.010 |
Why?
|
| Carbachol | 1 | 1999 | 4 | 0.010 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 1999 | 2 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 6 | 0.010 |
Why?
|
| Protein Kinase C-epsilon | 1 | 1999 | 2 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1999 | 18 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 149 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1998 | 24 | 0.010 |
Why?
|